Holen Sie sich die Stockscreener-App
2.52
0.80%
0.02
Vorhandelsmarkt:
2.55
0.03
+1.19%
Nrx Pharmaceuticals Inc Aktie (NRXP) Neueste Nachrichten
NRx Pharmaceuticals Advances Robotic-Enabled Transcranial Magnetic Stimulation Combined with Neuroplastic Therapy for Military and First Responder Applications - Investing News Network
FinancialContentMilitary and First Responder Opportunity for Robotic-Enabled Transcranial Magnetic Stimulation via Neuroplastic Therapy from NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) - FinancialContent
NRx Pharmaceuticals forms defense R&D subsidiary By Investing.com - Investing.com Australia
NRx Pharmaceuticals Advances Robotic TMS and Neuroplastic Therapy for Military and First Responders - citybiz
NRx Pharmaceuticals Forms Defense Subsidiary to Develop AI-Enabled Neuroplastic Therapies - citybiz
NRx says FDA finds no bioequivalence issues in ketamine filing - MSN
NRx aims robot-guided PTSD treatment at troops, first responders - Stock Titan
NRx Receives FDA Feedback on Ketamine Drug Labeling - MyChesCo
Earnings Miss: Is NRx Pharmaceuticals Inc vulnerable to short sellersTrade Performance Summary & Reliable Price Breakout Signals - baoquankhu1.vn
NRx Pharmaceuticals (NASDAQ: NRXP) Appoints First Chief Commercial Officer Ahead of Ketamine Launch - The Globe and Mail
NRx Pharmaceuticals Announces Appointment of Glenn Tyson as the Company's first Chief Commercial Officer - Investing News Network
NRx Pharmaceuticals names Glenn Tyson as chief commercial officer By Investing.com - Investing.com Canada
NRx Pharmaceuticals Appoints Glenn Tyson as Chief Commercial Officer Ahead of Anticipated Drug Approvals - Quiver Quantitative
NRx Pharmaceuticals (Nasdaq:NRXP) Announces Appointment of Glenn Tyson as the Company's first Chief Commercial Officer - Bitget
NRx Pharmaceuticals (Nasdaq:NRXP) Announces Appointment of Glenn Tyson as the Company’s first Chief Commercial Officer - GlobeNewswire Inc.
Published on: 2026-04-12 15:49:40 - baoquankhu1.vn
NRXP Forecast, Price Target & Analyst Ratings | NRX PHARMACEUTICALS INC (NASDAQ:NRXP) - ChartMill
Earnings Recap: Can NRx Pharmaceuticals Inc Equity Warrant outperform in the next rallyTrade Exit Report & Weekly Top Performers Watchlists - baoquankhu1.vn
NRx Pharmaceuticals Announces FDA Labeling Alignment for NRx's Preservative-Free Ketamine Application - marketscreener.com
NRx Pharmaceuticals, Inc. (NRXP) stock price, news, quote and history - Yahoo Finance UK
NRx Pharmaceuticals, Inc. (NRXPW) Stock Price, News, Quote & History - Yahoo! Finance Canada
NRx Pharmaceuticals Receives FDA Feedback on Preservative-Free Ketamine Label - National Today
NRx Pharmaceuticals Aligns FDA Labeling for Preservative-Free Ketamine Application - citybiz
NRx receives preliminary FDA alignment on ketamine labeling By Investing.com - Investing.com Canada
NRx Pharmaceuticals Receives Preliminary Labeling Alignment from FDA for Preservative-Free Ketamine Product - Quiver Quantitative
NRx Pharmaceuticals (Nasdaq:NRXP) Announces FDA Labeling Alignment for NRx’s Preservative-Free Ketamine Application - The Manila Times
FDA flags only minor label edits for U.S.-made ketamine amid backorders - Stock Titan
NRx Pharmaceuticals (NASDAQ: NRXP) Receives FDA Labeling Feedback for Preservative-Free Ketamine Application - The Globe and Mail
NRx Pharmaceuticals (Nasdaq:NRXP) Announces FDA Labeling Alignment for NRx's Preservative-Free Ketamine Application - Bitget
H.C. Wainwright raises NRx Pharmaceuticals stock price target to $45 - Investing.com
NRx Pharmaceuticals, Inc. (NRXPW) Analyst insights, Price targets and Recommendations - Yahoo Finance Singapore
NRXP Stock Price, Quote & Chart | NRX PHARMACEUTICALS INC (NASDAQ:NRXP) - ChartMill
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Acquires Kadima Institute to Launch $100M Psychiatry Clinic Network - MSN
NRX Pharmaceuticals (HAM:B1Q) PB Ratio : (As of Mar. 31, 2026) - GuruFocus
NRx Pharmaceuticals, Inc. (NRXPW) stock price, news, quote and history - Yahoo Finance Singapore
Hedge Fund Bets: Is NRx Pharmaceuticals Inc backed by strong institutional buyingEarnings Overview Report & Smart Money Movement Tracker - baoquankhu1.vn
AI-Powered 'Depression Thermometer' to Aid Interventional Psychiatry Network - National Today
AI-Powered “Depression Thermometer” to Aid Interventional Psychiatry Network via Strategic Partnership with Emobot for NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) - Barchart.com
Hope Therapeutics, an NRx Pharmaceuticals Subsidiary (Nasdaq:NRXP), Announces Strategic Partnership with Emobot to Integrate its AI-Powered "Depression Thermometer" Across its Interventional Psychiatry Network - Bitget
Hope Therapeutics, an NRx Pharmaceuticals Subsidiary, Announces Strategic Partnership with Emobot - citybiz
Hope Therapeutics, an NRx Pharmaceuticals Subsidiary (Nasdaq:NRXP), Announces Strategic Partnership with Emobot to Integrate its AI-Powered 'Depression Thermometer” Across its Interventional Psychiatry Network - The Manila Times
Hope Therapeutics, an NRx Pharmaceuticals Subsidiary (Nasdaq:NRXP), Announces Strategic Partnership with Emobot to Integrate its AI-Powered “Depression Thermometer” Across its Interventional Psychiatry Network - ChartMill
A phone app aims to catch depression relapse between clinic visits - Stock Titan
NRx says FDA will review NRX-100 without new trials - MSN
NRx Pharmaceuticals (NASDAQ:NRXP) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Has Found A Path To Profitability - simplywall.st
Nrx Pharmaceuticals’ Earnings Call Signals High‑Stakes Progress - The Globe and Mail
Published on: 2026-03-29 11:07:47 - baoquankhu1.vn
NRX Pharmaceuticals (HAM:B1Q) Cyclically Adjusted PS Ratio : (As of Apr. 01, 2026) - GuruFocus
Can NRx Pharmaceuticals Inc scale operations efficiently2026 Weekly Recap & Weekly High Potential Stock Alerts - baoquankhu1.vn
NRX Pharmaceuticals (HAM:B1Q) PB Ratio : (As of Mar. 28, 2026) - GuruFocus
Insider Buy: Is NRx Pharmaceuticals Inc a stock for growth or value investors2026 Breakouts & High Accuracy Trade Alerts - baoquankhu1.vn
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Q4 2025 Earnings Call Transcript - Insider Monkey
Analysts Are Bullish on Top Healthcare Stocks: NRX Pharmaceuticals (NRXP), Rezolute (RZLT) - The Globe and Mail
NRx Pharmaceuticals, Inc. (NRXP) surpasses Q4 earnings estimates - MSN
NRx Pharmaceuticals (NRXP) Looks to Score Double With ANDA and NDA Filings For NRX-101 - Insider Monkey
NRx Pharmaceuticals, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Nrx Pharmaceuticals: Extensive Clinical, Regulatory, and Financial Risks Make Shares Highly Speculative - tipranks.com
2.69%
0.25%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):